Year: 2012

December 13, 2012

Photo: Discussing Parkinson’s research

Jeff Balser, M.D., Ph.D., left, discusses Vanderbilt’s drug discovery program during a congressional briefing Nov. 29 in Washington, D.C.

By VUMC News and Communications
December 13, 2012

Patients, families at heart of new ‘Promise’ campaign

Vanderbilt University Medical Center is taking its commitment to a patient-centered experience to a new level through the Vanderbilt Patient and Family Promise, a six-point commitment statement being rolled out publicly in February.

By Nancy Humphrey
December 13, 2012

Quality, innovation key to VUMC’s fiscal health: Balser

As medical centers across the country respond to declining revenue streams and a federal budget crisis, focusing on the quality of the patient experience becomes ever more important.

By Paul Govern
December 13, 2012

CDC selects VU to lead national adverse vaccine event reviews

Vanderbilt University Medical Center has been selected by the Centers for Disease Control and Prevention (CDC), to lead a consortium of top national experts in vaccine safety in performing timely reviews of adverse vaccine events.

By VUMC News and Communications
December 13, 2012

New Neurology residency program director brings global perspective

After a decade of growth in the Department of Neurology’s residency program, Heather Koons, M.D., is stepping into the role of program director and brings a uniquely international perspective.

By VUMC News and Communications
December 12, 2012

Genes, nutrients interact to shape traits

A new study identifies interactions between genes and nutrients that may participate in determining levels of cholesterol and triglycerides.

By Leigh MacMillan
December 10, 2012

Genetic clues to lung scarring

A rare genetic syndrome provides new clues to lung scarring (pulmonary fibrosis), a potentially deadly consequence of many lung diseases.
By VUMC News and Communications
December 7, 2012

Vanderbilt study finds diverse genetic alterations in triple-negative breast cancers

Most triple-negative breast cancer patients who were treated with chemotherapy to shrink the tumor prior to surgery still had multiple genetic mutations in their tumor cells, according to a study by Vanderbilt-Ingram Cancer Center (VICC) investigators.
By VUMC News and Communications
December 7, 2012

Breast milk blocks virus binding

Components of human breast milk help ward off viral infection, a new study shows.
By VUMC News and Communications
December 6, 2012

Vice Chancellor Balser: ‘Cliff’ looming for biomedical research

"Beyond the damaging effects on the health of our people, disrupting the nation’s biomedical science infrastructure puts our economic future at risk," writes Vice Chancellor for Health Affairs Jeff Balser in The Tennessean.
By VUMC News and Communications
December 6, 2012

Sugarplum fairy visits Children’s Hospital

By VUMC News and Communications
December 6, 2012

Hudson lands top award from matrix biology group

Billy Hudson, Ph.D., an internationally known expert on kidney diseases at Vanderbilt University, is the recipient of the 2012 Senior Investigator Award from the American Society for Matrix Biology (ASMB) — its highest honor.
By Bill Snyder